Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP398836.RAZkR1HomC-enzBL9gYUnyO3IEZ1WEpiqf_84l0ntzoDk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP398836.RAZkR1HomC-enzBL9gYUnyO3IEZ1WEpiqf_84l0ntzoDk130_assertion type Assertion NP398836.RAZkR1HomC-enzBL9gYUnyO3IEZ1WEpiqf_84l0ntzoDk130_head.
- NP398836.RAZkR1HomC-enzBL9gYUnyO3IEZ1WEpiqf_84l0ntzoDk130_assertion description "[Tubes contained either growth factor-reduced basement membrane extract (BME)-alone (negative control) or BME-containing vascular endothelial growth factor (VEGF)-D (positive control for lymphangiogenesis) or FGF-2/VEGF-A (positive control for angiogenesis) or a high VEGF-D-expressing breast cancer cell line MDA-MD-468LN (468-LN), or VEGF-D-silenced 468LN.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP398836.RAZkR1HomC-enzBL9gYUnyO3IEZ1WEpiqf_84l0ntzoDk130_provenance.
- NP398836.RAZkR1HomC-enzBL9gYUnyO3IEZ1WEpiqf_84l0ntzoDk130_assertion evidence source_evidence_literature NP398836.RAZkR1HomC-enzBL9gYUnyO3IEZ1WEpiqf_84l0ntzoDk130_provenance.
- NP398836.RAZkR1HomC-enzBL9gYUnyO3IEZ1WEpiqf_84l0ntzoDk130_assertion SIO_000772 23711825 NP398836.RAZkR1HomC-enzBL9gYUnyO3IEZ1WEpiqf_84l0ntzoDk130_provenance.
- NP398836.RAZkR1HomC-enzBL9gYUnyO3IEZ1WEpiqf_84l0ntzoDk130_assertion wasDerivedFrom befree-20150227 NP398836.RAZkR1HomC-enzBL9gYUnyO3IEZ1WEpiqf_84l0ntzoDk130_provenance.
- NP398836.RAZkR1HomC-enzBL9gYUnyO3IEZ1WEpiqf_84l0ntzoDk130_assertion wasGeneratedBy ECO_0000203 NP398836.RAZkR1HomC-enzBL9gYUnyO3IEZ1WEpiqf_84l0ntzoDk130_provenance.